Merit Financial Group LLC reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 36.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,278 shares of the biopharmaceutical company’s stock after selling 6,994 shares […]